最新ニュース Krispy Kreme (NASDAQ:DNUT) 株価情報

Krispy Kreme

Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.

Krispy Kreme Inc

<a href="https://www.ft.com/content/bc4465d2-59ae-41fd-8b1a-8c39a9091cd4" title="https://www.ft.com/content/bc4465d2-59ae-41fd-8b1a-8c39a9091cd4">https://www.ft.com/content/bc4465d2-59ae-41fd-8b1a-8c39a9091cd4</a>

News

AMZN

'Jeff Bezos To Sell Up To $4.75bn In Amazon Stock'

Barclays analyst Duffy Fischer maintains Air Products &amp; Chemicals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APD#NYSE">APD</a>) with a Overweight and lowers the price target from $355 to $325.

Price Target

Analyst Ratings

Barclays Maintains Overweight on Air Products & Chemicals, Lowers Price Target to $325

Barclays analyst Alex Scott maintains American International Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIG#NYSE">AIG</a>) with a Overweight and raises the price target from $92 to $93.

Barclays Maintains Overweight on American International Gr, Raises Price Target to $93

Ryde Group (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#AMEX">RYDE</a>) reported quarterly losses of $(0.63) per share. This is a 16 percent increase over losses of $(0.75) per share from the same period last year. The company reported $6.55 million in sales this quarter. This is a 0.27 percent decrease over sales of $6.57 million the same period last year.

Earnings

RYDE

Ryde Group FY GAAP EPS $(0.63) Up From $(0.75) YoY, Sales $6.55M Down From $6.57M YoY

Cantor Fitzgerald analyst Deepak Mathivanan maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Underweight and lowers the price target from $101 to $100.

ABNB

Cantor Fitzgerald Maintains Underweight on Airbnb, Lowers Price Target to $100

Cigna Group&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) on Friday reported first-quarter 2025 revenue of $65.45 billion, beating analyst <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">estimates of $60.39 billion</a>.
Sales increased 14% year over year, reflecting the growth of existing client relationships and strong specialty pharmacy growth in <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/n45160757/the-cigna-group-reports-strong-first-quarter-2025-results-raises-2025-outlook" rel="noreferrer noopener">Evernorth Health Services</a>.
The company reported adjusted earnings of $6.74 per share, beating <a target="_blank" href="https://www.benzinga.com/25/05/45158861/cigna-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts" rel="noreferrer noopener">analysts&#8217; estimates of $6.35</a>.
Evernorth Health Services, including Pharmacy Benefit and Specialty and Care Services, reported first-quarter sales of $53.68 billion, up 16%.
<ul>
<li>Pharmacy Benefit Services sales reached $29.74 billion, 14% reflecting existing client relationships and new business growth.</li>
<li>&nbsp;Specialty and Care Services sales reached $23.94 billion, up 19%, reflecting strong specialty volume growth.</li>
</ul>
Also Read: <a target="_blank" href="https://www.benzinga.com/general/health-care/25/04/44627279/ftc-pauses-lawsuit-against-cvs-cigna-unitedhealths-pbms-amid-commissioner-shortage" rel="noreferrer noopener">FTC Pauses Lawsuit Against CVS, Cigna, UnitedHealth&#8217;s PBMs Amid Commissioner Shortage</a>
Cigna Healthcare segment sales increased 9% to $14.48 billion, primarily reflecting premium rate increases to cover expected increases in underlying medical costs.
<ul>
<li>The Cigna Healthcare medical cost ratio (MCR)&nbsp;was 82.2% for the first quarter of 2025, compared to 79.9% a year ago, primarily due to expected higher stop loss medical costs.</li>
<li>The Health Care Services Corporation&nbsp;(HCSC) transaction&nbsp;closed later than the company&#8217;s financial planning assumptions, increasing the first quarter Cigna Healthcare MCR&nbsp;as the Medicare businesses operate at a higher MCR&nbsp;than the rest of the portfolio.</li>
</ul>
Cigna ended the March quarter with total medical customers decreasing 6% from Dec. 31, 2024, to 18.04 million, primarily reflecting the impact of the HCSC transaction.
<ul>
<li>Excluding the impact of the HCSC transaction, total medical customers&nbsp;as of&nbsp;March 31, 2025, were consistent with&nbsp;December 31, 2024.</li>
</ul>
Total customer relationships stood at 182.2 million&nbsp;at&nbsp;March 31, 2025.
<ul>
<li>Excluding the impact of the HCSC transaction, total customer relationships increased 1% from Dec. 31, 2024.</li>
</ul>
Total pharmacy customers as of March 31, 2025, increased 3% from Dec. 31, 2024, to 122.3 million due to new sales and the continued expansion of relationships.
&#8220;Our strong first quarter results and increase in outlook for full-year earnings reflects the strength of our Evernorth Health Services and Cigna Healthcare growth platforms in a dynamic environment,&#8221; said David Cordani, chairman and CEO of the Cigna Group. 
Outlook:&nbsp;Cigna expects fiscal 2025 adjusted income per share of $29.60, <a target="_blank" href="https://www.benzinga.com/news/earnings/25/01/43337308/cigna-stock-dives-on-q4-earnings-miss-we-are-taking-corrective-actions-to-address-these-near-term-pressures" rel="noreferrer noopener">up from $29.50</a> versus the consensus of $29.60
The company expects Evernorth&#8217;s adjusted income from operations (pre-tax of at least $7.2 billion, with at least $4.125 billion for Cigna Healthcare.
Cigna Healthcare Medical Care Ratio is expected to be between 83.2% to 84.2%.
CI Price Action: Cigna stock is up 2.93% at $344.99 during the premarket session at publication on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/buybacks/25/05/45164086/chevron-q1-profit-drops-on-higher-costs-weak-international-margins" target="_blank" rel="noreferrer noopener">Chevron Q1 Profit Drops On Higher Costs, Weak International Margins</a></li>
</ul>
Photo: Shutterstock

Large Cap

Guidance

Health Care

Movers

Trading Ideas

Insurance

General

Cigna CEO Says Strong Q1 Earnings, Increased Outlook Reflect Strength In Growth Platforms

Wells Fargo analyst Andrew Bauch downgrades Block (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYZ#NYSE">XYZ</a>) from Overweight to Equal-Weight and lowers the price target from $95 to $50.

Downgrades

Wells Fargo Downgrades Block to Equal-Weight, Lowers Price Target to $50

Wells Fargo analyst Nathan Treybeck upgrades iRhythm Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRTC#NASDAQ">IRTC</a>) from Equal-Weight to Overweight and raises the price target from $104 to $130.

Upgrades

IRTC

Wells Fargo Upgrades iRhythm Technologies to Overweight, Raises Price Target to $130

Evercore ISI Group analyst Durgesh Chopra maintains Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) with a Outperform and raises the price target from $331 to $360.

Evercore ISI Group Maintains Outperform on Quanta Services, Raises Price Target to $360

<ul>
<li>AAPL</li>
<li>AMZN</li>
<li>TSLA</li>
<li>BULL</li>
<li>RDDT</li>
<li>GLD</li>
<li>MSTR</li>
<li>NVDA</li>
<li>DE</li>
<li>QQQ</li>
</ul>
Data from <a href="https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment">https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment</a>
&nbsp;

AAPL

BULL

MSTR

NVDA

RDDT

TSLA

Top 10 Trending Stocks On WallStreetBets As Of May 2, 2025 (Via Swaggy Stocks)

Evercore ISI Group analyst Steve Sakwa maintains Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>) with a In-Line and raises the price target from $297 to $309.

Evercore ISI Group Maintains In-Line on Public Storage, Raises Price Target to $309

WIIM

Cooper-Standard Holdings shares are trading higher after the company reported better-than-expected Q1 financial results.

Cantor Fitzgerald analyst Deepak Mathivanan maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Overweight and raises the price target from $230 to $240.

Cantor Fitzgerald Maintains Overweight on Amazon.com, Raises Price Target to $240

FuboTV&nbsp;Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>)&nbsp;reported&nbsp;earnings for the&nbsp;<a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45162938/fubos-global-streaming-business-exceeded-subscriber-guidance-achieved-revenue-targets-in-q1-2025" rel="noreferrer noopener">first-quarter&nbsp;of 2025</a> on Friday. The stock price declined after the results.
Revenue of the sports-first live TV streaming platform grew 8.1%&nbsp;year over year&nbsp;to $405.96 million, marginally missing the&nbsp;analyst&nbsp;consensus estimate of $415.45 million.
Adjusted EPS loss of 2 cents beat the <a href="https://www.benzinga.com/calendars/earnings" target="_blank" rel="noreferrer noopener">analyst consensus estimate</a> of 9 cents.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/02/44042301/fubotv-projects-subscriber-fall-in-q1-after-q4-topline-growth-stock-tumbles" target="_blank" rel="noreferrer noopener">FuboTV Projects Subscriber Fall In Q1 After Q4 Topline Growth, Stock Tumbles</a>
The company's adjusted EBITDA margin loss stood at .3% versus 9.9% Y/Y. 
North America Streaming:&nbsp;Revenue grew 3.5% Y/Y to $407.9 million, as paid subscribers declined 2.7% Y/Y to 1.47 million. Average revenue per user (ARPU) rose 1.0% Y/Y to $85.37.
Rest of the World Streaming: Revenue was $8.4 million, a 0.4% Y/Y decline, and paid subscribers declined 10.9% Y/Y to 354,000. ARPU grew by 10.9% Y/Y to $7.76.
As of March 31, FuboTV held $327.8 million in cash and equivalents. The company used $61.99 million in free cash flow in the quarter, compared to $71.3 million from a year ago.
Outlook:&nbsp;FuboTV expects second-quarter North American revenue of $340 million–$350 million and ROW revenue of $6.5 million-$7.5 million versus consensus of&nbsp;$387.68 million <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">analyst consensus estimate</a>.
Fubo expects 1.55 million-1.59 million total subscribers by the quarter.
It estimates North American subscribers to be 1.225 million-1.255 million, representing a 14% Y/Y decline at the midpoint.
It projects ROW 325,000-335,000 subscribers, representing a 17% Y/Y decline at the midpoint.
Price Action: Fubo stock traded lower by 7.51% at $2.71 premarket at last check on Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/sports/25/04/44875151/fubo-extends-soccer-reign-in-canada-with-premier-league-renewal" target="_blank" rel="noreferrer noopener">Fubo Extends Soccer Reign In Canada With Premier League Renewal</a></li>
</ul>
Image: Logo courtesy of Fubo

FUBO

FuboTV Stock Drops After Q1 Subscriber Losses And Lower-Than-Expected Outlook

<ul>
<li>It is estimated that by 2030 the prevalence of MASH (Metabolic Dysfunction-Associated Steatohepatitis) in the Canadian general population will increase from 5.2% to 6.5%.1&nbsp;</li>
<li>Left untreated, MASH can progress to serious and even fatal outcomes, such as cirrhosis, liver cancer, and the need for liver transplant.2&nbsp;</li>
</ul>
&nbsp;

Health Canada Accepts Semaglutide 2.4 mg As Supplemental New Drug Submission Under Priority Review Policy

Evercore ISI Group analyst Cory Kasimov maintains Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) with a In-Line and lowers the price target from $50 to $32.

MRNA

Evercore ISI Group Maintains In-Line on Moderna, Lowers Price Target to $32

TNMG

TNL Mediagene shares are trading lower after the company reported a year-over-year decrease in FY24 EPS results.

<a href="https://x.com/TvAlmasirah/status/1918290745770889474" title="https://x.com/TvAlmasirah/status/1918290745770889474">https://x.com/TvAlmasirah/status/1918290745770889474</a>

Macro Economic Events

Economics

iShares MSCI Israel Capped Investable Market Index Fund

Houthi-Linked Channel, Al Masirah TV, On X Shares Statement Regarding Military Operation Targeting Israeli In Haifa Area

Evercore ISI Group analyst Michael Binetti maintains Kohl's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KSS#NYSE">KSS</a>) with a In-Line and lowers the price target from $9 to $8.

Evercore ISI Group Maintains In-Line on Kohl's, Lowers Price Target to $8

AMWL

American Well shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance with its midpoint above estimates.

Comments

Krispy Kreme

ニュース

最新ニュース Krispy Kreme (NASDAQ:DNUT) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル